Reata Pharmaceuticals, Inc. (RETA) NASDAQ
172.36
+0.04(+0.02%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.38B |
| Enterprise Value | 1.46B |
| P/E Ratio | -20.07 |
| PEG Ratio | -0.38 |
| Price/Sales Ratio | 2,963.2 |
| Price/Book Ratio | -95.29 |
| Enterprise/Revenue | 2,998.02 |
| Enterprise/EBITDA | -24.7 |
Fiscal Year
| Fiscal Year | December 31, 2022 |
| Most Recent Quarter | June 30, 2023 |
Profitability
| Profit Margin | -140.75 |
| Operating Margin | -121.91 |
Management Effectiveness
| Return On Assets | -0.61 |
| Return On Equity | 0.47 |
Income Statement
| Revenue | 2.22M |
| Revenue/Share | 0.06 |
| Gross Profit | 2.22M |
| EBITDA | -269.02M |
| Net Income | -311.9M |
| Diluted EPS | -8.59 |
Balance Sheet
| Total Cash | 330.21M |
| Total Cash/Share | 10.67 |
| Total Debt | 166M |
| Total Debt/Equity | -1.82 |
| Current Ratio | 6.75 |
| Book Value Per Share | -1.81 |
Price History
| 52-Week Change | 424.85 |
| 52-Week High | 172.46 |
| 52-Week Low | 21.83 |
| Moving Average 50 Days | 157.27 |
| Moving Average 200 Days | 94.36 |
Statistics
| Average Volume | 954,093 |
| Shares Outstanding | 38.1M |
| % Held by Institutions | 0.27 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
